| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/18/2013 | US20130095192 Resuscitation fluid |
| 04/18/2013 | US20130095188 Method of Encapsulating a Material Using Solvent Removal Technique, and Microspheres/Nanospheres/Matrix Made Therefrom Having Sustained Release Properties |
| 04/18/2013 | US20130095187 Composition for nucleic acid delivery using metal nanoparticles and preparing method thereof |
| 04/18/2013 | US20130095186 Temperature-sensitive carrier for carrying a physiologically active substance and preparation method thereof |
| 04/18/2013 | US20130095185 Stabilized topical formulations containing core-shell microcapsules |
| 04/18/2013 | US20130095181 Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyriodin-2-yl)benzoic acid and administration thereof |
| 04/18/2013 | US20130095177 Method of preparing an oral dosage form comprising fingolimod |
| 04/18/2013 | US20130095176 Controlled release drug delivery compostion |
| 04/18/2013 | US20130095172 Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab |
| 04/18/2013 | US20130095171 Herbal composition and method for treatment of airway inflammation using the same |
| 04/18/2013 | US20130095168 Transdermal drug delivery system containing donepezil |
| 04/18/2013 | US20130095167 Customized compositions and uses thereof |
| 04/18/2013 | US20130095165 Stabilizers for hemostatic products |
| 04/18/2013 | US20130095157 Cosmetic composition containing retinol stabilized by porous polymer beads and nanoemulsion |
| 04/18/2013 | US20130095156 Rapidly disintegrating films for delivery of pharmaceutical or cosmetic agents |
| 04/18/2013 | US20130095155 Topical vitamin d and ubiquinol oral supplement compositions |
| 04/18/2013 | US20130095154 Topical vitamin d oral supplement compositions |
| 04/18/2013 | US20130095153 Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery |
| 04/18/2013 | US20130095150 Stabilized active compound |
| 04/18/2013 | US20130095149 Process for the preparation of controlled-release solid formulations containing oxcarbazepine, and formulations obtainable by said process |
| 04/18/2013 | US20130095148 Dosage Forms for Tamper Prone Therapeutic Agents |
| 04/18/2013 | US20130095146 Ciclesonide containing aqueous pharmaceutical composition |
| 04/18/2013 | US20130095145 Preparation for Transnasal Application |
| 04/18/2013 | US20130095144 Pharmaceutical compositions of sirolimus |
| 04/18/2013 | US20130095142 Lipid Emulsion Having Krill Oil As An Active Ingredient And Preparation Method Therefor |
| 04/18/2013 | US20130095140 Biguanide Compositions and Methods of Treating Metabolic Disorders |
| 04/18/2013 | US20130095042 Silica-based nanoparticles and methods of stimulating bone formation and suppressing bone resorption through modulation of nf-kb |
| 04/18/2013 | US20130095032 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 04/18/2013 | US20130092160 Compositions, methods & systems for respiratory delivery of two or more active agents |
| 04/18/2013 | DE19780440B3 Insektizidkombination gegen Läuse von Säugern, insbesondere von Hunden und Katzen Insecticide combination against lice of mammals, especially dogs and cats |
| 04/18/2013 | DE10306344B4 Gasspeicher zur Speicherung einer vorgegebenen Gasmenge und Freigabe des Gases für eine medizinische Applikation Gas storage for storing a predetermined amount of gas and release of gas for medical application |
| 04/18/2013 | DE102011116069A1 Lipidnanopartikeldispersion, Verfahren zu deren Herstellung sowie ihre Verwendung Lipid nanoparticle dispersion, process for their preparation and their use |
| 04/18/2013 | CA2852995A1 Ocular composition containing bromfenac with increased bioavailability |
| 04/18/2013 | CA2852068A1 In situ forming hydrogel and method using same |
| 04/18/2013 | CA2852064A1 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof |
| 04/18/2013 | CA2852063A1 Phytoglycogen-based compositions, materials and methods |
| 04/18/2013 | CA2852058A1 Solid dispersion |
| 04/18/2013 | CA2852055A1 Dietary supplements with rapid buccal dissolution |
| 04/18/2013 | CA2851765A1 A gastroretentive dosage system and process of preparation thereof |
| 04/18/2013 | CA2851764A1 Compositions comprising salbutamol sulphate |
| 04/18/2013 | CA2851588A1 Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy)-1h-quinolin-2-one or a salt thereof |
| 04/18/2013 | CA2851566A1 Novel coating system |
| 04/18/2013 | CA2851522A1 Buffered oxygen therapeutic |
| 04/18/2013 | CA2851433A1 R(+)-n-methyl-propargyl-aminoindan |
| 04/18/2013 | CA2851276A1 R(+)-n-formyl-propargyl-aminoindan |
| 04/18/2013 | CA2851274A1 Rasagiline citramide |
| 04/18/2013 | CA2851131A1 Ophthalmic composition containing cyclosporin and method for preparing same |
| 04/18/2013 | CA2851026A1 Compositions comprising salbutamol sulphate |
| 04/18/2013 | CA2850084A1 Crystalline microparticles of a beta-agonist coated with a fatty acid |
| 04/18/2013 | CA2849538A1 Porphyrin microbubbles |
| 04/18/2013 | CA2849192A1 Prevention and treatment of ocular conditions |
| 04/17/2013 | EP2581374A1 Preparation of tetrahydropyrido[4,3-b]indole derivatives |
| 04/17/2013 | EP2581085A1 Pharmaceutical composition for nasal administration of metopimazine |
| 04/17/2013 | EP2581084A1 Solid dispersion comprising triazole compound |
| 04/17/2013 | EP2581079A1 Combination of hyaluronic acid and prilocaine |
| 04/17/2013 | EP2581078A1 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| 04/17/2013 | EP2580248A1 An enzymatic method of producing a hydrogel from xylan |
| 04/17/2013 | EP2580215A2 8-(2'-heterocycyl)pyrido[2.3-d]pyrimidin-7(8h)-ones for the treatment of cns disorders |
| 04/17/2013 | EP2579973A1 Apparatus and method for the production of particles |
| 04/17/2013 | EP2579896A1 Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution |
| 04/17/2013 | EP2579880A1 Treatment of type 2 diabetes |
| 04/17/2013 | EP2579879A1 Treatment of type 1 diabetes |
| 04/17/2013 | EP2579875A2 Compositions comprising buprenorphine |
| 04/17/2013 | EP2579874A2 Injectable flowable composition comprising buprenorphine |
| 04/17/2013 | EP2579869A2 Formulations including amiodarone and salts thereof and methods of their manufacture and use |
| 04/17/2013 | EP2579863A2 Compounds for treatment of bovine mastitis |
| 04/17/2013 | EP2579862A1 Pharmaceutical composition with olive extract (hydroxytyrosol) and hop extract (xanthohumol) for intranasal application |
| 04/17/2013 | EP2579860A2 Ivabradine-containing pharmaceutical composition with modified release |
| 04/17/2013 | EP2579859A2 Solid ivabradine-containing composition |
| 04/17/2013 | EP2579858A2 Ivabradine-containing pharmaceutical composition |
| 04/17/2013 | EP2579857A1 Alcohol-resistant extended release dosage forms comprising venlafaxine |
| 04/17/2013 | EP2579856A1 An injectable dosage form of flupirtine |
| 04/17/2013 | EP2579855A2 Solid dispersions containing kinase inhibitors |
| 04/17/2013 | EP2579854A1 Solid compositions |
| 04/17/2013 | EP2579853A1 Method of preparaing enteric hard capsule and enteric hard capsule prepared thereby |
| 04/17/2013 | EP2579852A1 A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid |
| 04/17/2013 | EP2579851A2 High oil-content emollient aerosol foam compositions |
| 04/17/2013 | EP2579850A1 Novel process |
| 04/17/2013 | EP2579849A1 Novel process |
| 04/17/2013 | EP2579848A2 Process for the preparation of o/w emulsions |
| 04/17/2013 | EP2579847A1 Antimycotic pharmaceutical composition |
| 04/17/2013 | EP2579845A1 Ophthalmic compositions for the administration of liposoluble acitve ingredients |
| 04/17/2013 | EP2579844A1 Nanoparticle film delivery systems |
| 04/17/2013 | EP2494956A9 Paclitaxel/steroidal complex |
| 04/17/2013 | EP2014304B9 Colon cleansing compositions |
| 04/17/2013 | CN202875848U Plaster with acupoint marks |
| 04/17/2013 | CN202875847U Magnetic Chinese herbal dressing for treating scars |
| 04/17/2013 | CN202875846U Capsule shell structure |
| 04/17/2013 | CN202875845U Cancer-preventing/treating and anti-aging tablet structure |
| 04/17/2013 | CN1604788B High-concentration protein formulations and method of manufacture |
| 04/17/2013 | CN103052398A Stabilization of fsh |
| 04/17/2013 | CN103052392A Treatment of lung infections by administration of tobramycin by aerolisation |
| 04/17/2013 | CN103052391A Pyrroloquinoline quinone gel |
| 04/17/2013 | CN103052385A Methods of treatment of hepatocellular carcinoma |
| 04/17/2013 | CN103052384A Aqueous composition comprising bromhexine |
| 04/17/2013 | CN103052383A Formulation comprising a type B lantibiotic |
| 04/17/2013 | CN103052382A Solid dispersion of alfa-ketoamide derivatives |
| 04/17/2013 | CN103052381A Composition comprising shellac and/or a salt thereof and sodium starch glycolate |
| 04/17/2013 | CN103052380A Humidified particles comprising a therapeutically active substance |
| 04/17/2013 | CN103052379A Dry powder formulation comprising a phosphodiesterase inhibitor |